EPISODE · Dec 11, 2025 · 38 MIN
JAK Inhibitors in Rheumatoid Arthritis: Overcoming Challenges and Maximizing Impact
from Keeping Current CME
See where Janus kinase (JAK) inhibitors fit into rheumatoid arthritis (RA) treatment to tackle obstacles and improve patient outcomes. Credit available for this activity expires: 12/10/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/jak-inhibitors-rheumatoid-arthritis-overcoming-challenges-2025a1000yav?ecd=bdc_podcast_libsyn_mscpedu
Embed this episode
NOW PLAYING
JAK Inhibitors in Rheumatoid Arthritis: Overcoming Challenges and Maximizing Impact
0:00
38:19
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Keeping Current CME?
This episode is 38 minutes long.
When was this Keeping Current CME episode published?
This episode was published on December 11, 2025.
Can I download this Keeping Current CME episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!